Analysts Set Cognition Therapeutics, Inc. (NASDAQ:CGTX) Target Price at $8.30
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […]
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […]
